The Effect of Curcumin on Corneal Neovascularization in Rabbit Eyes

REFERENCES

• Chang JH, Gabison EE, Kato T, et al. Corneal neovascularization. Curr Opin Ophthalmol. 2001;12:242–249.
   PubMed Web of Science ®Google Scholar
• Cursiefen C, Kuchle M, Naumann GO. Angiogenesis in corneal diseases: Histopathologic evaluation of 254 human corneal buttons with neovascularization. Cornea. 1998;17:611–613.
   Google Scholar
• Phillips K, Arffa R, Cintron C. Effect of prednisolone and medroxy progesterone on corneal wound healing, ulceration, and neovascularization. Arch Ophthalmol. 1983;101:640–643.
   PubMed Web of Science ®Google Scholar
• Crum R, Szabo S, Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science. 1986;230:1375–1378.
   Google Scholar
• Murata M, Shimizu S, Houriuchi S, et al. Inhibitory effect of triamcinolone acetonide on corneal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2006;244:205–209.
   PubMed Web of Science ®Google Scholar
• Hayness WL, Proia AD, Klintworth GK. Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest Ophthalmol Vis Sci. 1989;30:1588–1593.
   PubMedGoogle Scholar
• Benelli U, Ross JR, Nardi M, et al. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci. 1997;38:274–282.
   PubMed Web of Science ®Google Scholar
• Primbs GB, Casey R, Wamser K, et al. Photodynamic therapy for corneal neovascularization. Ophthalmic Surg Lasers. 1998;29:832–838.
   PubMedGoogle Scholar
• Yoon KC, You IC, Kang IS, et al. Photodynamic therapy with verteporfin for corneal neovascularization. Am J Ophthalmol. 2007;144:390–395.
   PubMed Web of Science ®Google Scholar
• Mendelsohn AD, Stock EL, Lo GG, et al. Laser photocoagulation of feeder vessels in lipid keratopathy. Ophthalmic Surg. 1986;17:502–508.
   Google Scholar
• Shao C, Sima J, Zhang SX, et al. Suppression of corneal neovascularization by PEDF release from human amniotic membranes. Invest Ophthalmol Vis Sci. 2004;45:1758–1762.
   PubMed Web of Science ®Google Scholar
• Frucht-Pery J, Siganos CS, Solomon A, et al. Limbal cell autograft transplantation for severe ocular surface disorders. Graefes Arch Clin Exp Ophthalmol. 1998;236:582–587.
   PubMed Web of Science ®Google Scholar
• Amano S, Rohan R, Kuroki M, et al. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci. 1998;39:18–22.
   PubMed Web of Science ®Google Scholar
• Edelman JL, Castro MR, Wen Y. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Invest Ophthalmol Vis Sci. 1999;40:1112–1123.
   PubMed Web of Science ®Google Scholar
• Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431–436.
   PubMed Web of Science ®Google Scholar
• Chariot A, Meuwis MA, Bonif M, et al. NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targets. Curr Med Chem. 2003;10:593–602.
   PubMedGoogle Scholar
• De Martin R, Hoeth M, Hofer-Warbinek R, et al. The transcription factor NF kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol. 2000;20:83–88.
   PubMed Web of Science ®Google Scholar
• Josko J, Mazurek M. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit. 2004;10:89–98.
   Google Scholar
• Tong Q, Zheng L, Lin L, et al. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NF-kappaB signaling pathway. Respir Res. 2006;7:37.
   Google Scholar
• Araujo CC, Leon LL. Biological activities of Curcuma longa. Mem Inst Oswaldo Cruz. 2001;96:723–728.
   PubMed Web of Science ®Google Scholar
• Menon LG, Kuttan R, Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett. 1995;95:221–225.
   PubMed Web of Science ®Google Scholar
• Phan TT, See P, Lee ST, et al. Protective effects of curcumin against oxidative damage on skin cells in vitro: Its implication for wound healing. J Trauma. 2001;51:927–931.
   PubMed Web of Science ®Google Scholar
• Bierhaus A, Zhang Y, Quehenberger P, et al. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb Haemost. 1997;77;772–782.
   PubMed Web of Science ®Google Scholar
• Singh S, Aggarwal BB. Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem. 1995;270:24995–5000.
   PubMed Web of Science ®Google Scholar
• Jobin C, Bradham CA, Russo MP, et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999;163:3474–3483.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang MC, Hu YZ, et al. Inhibition of rat corneal neovascularization by inhibitor of nuclear factor-kappaB. Zhonghua Yan Ke Za Zhi. 2005;41:1124–1128.
   Google Scholar
• Maheshwari RK, Singh AK, Gaddipati J, et al. Multiple biological activities of curcumin: A short review. Life Sci. 2006;78:2081–2087.
   PubMed Web of Science ®Google Scholar
• Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med. 1998;4:376–383.
   PubMed Web of Science ®Google Scholar
• Gururaj AE, Belakavadi M, Venkatesh DA, et al. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun. 2002;297:934–942.
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB regulated gene products. Cancer Res. 2007;67:3853–3861.
   PubMed Web of Science ®Google Scholar
• Lin YG, Kunnumakkara AB, Nair A, et al. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res. 2007;13:3423–3430.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Yamagishi S, Inagaki Y, et al. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB. 2002;16:1928–1930.
   PubMed Web of Science ®Google Scholar
• Bian F, Zhang MC, Zhu Y. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo. Ophthalmologica. 2008;222:178–186.
   PubMed Web of Science ®Google Scholar
• Mohan R, Sivak J, Ashton P, et al. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem. 2000;275:10405–10412.
   PubMed Web of Science ®Google Scholar
• Kunwar A, Barik A, Mishra B, et al. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and turmor cells. Biochim Biophys Acta. 2008:1780:673–679.
   PubMed Web of Science ®Google Scholar